DARA BioSciences, Inc. (DARA)

[Investor100]

DARA @ Stockcharts

Nice movement forward with 3% gainer..2M shares and MFI turning up and 200MA..follow the $$!

Nice catalyst coming up too:)

ARA is focused on expanding its portfolio of oncology supportive care products in the United States, via in-licensing and/or partnering of complementary late-stage and approved products. In addition, the company wishes to identify a strategic partner for the clinical development of KRN5500, currently in Phase 2 for the treatment of chronic, treatment refractory, chemotherapy-induced peripheral neuropathy (CCIPN). The FDA has designated KRN5500 as a Fast Track Drug, and DARA is seeking orphan status for the treatment of CCIPN.